Close Menu


The alliance may help partner companies Agilent, Fluidigm, NuGen, and RainDance Technologies grab a piece of the sequencing market share that Pacific Biosciences is expected to secure when it launches its third-generation sequencer later this year.

The single-molecule sequencing technology company has named the 11 firms that are the initial members of its new partner program, which is aimed at providing customers with complete solutions.

Enigma struck the alliance with Tecan in anticipation of a fourth-quarter commercial launch of its miniaturized PCR instrument for point-of-care influenza diagnostic tests in Europe in partnership with GlaxoSmithKline.

Tecan will manufacture Enigma's new point-of-care molecular diagnostic instrument under a five-year deal.

New Products: Dec 8, 2009


Fluidigm 48.48 Access Array, DNAStar Lasergene v8.1, NuGen Ovation RNA-seq

Product Watch: Dec 3, 2009


Thermo Fisher's Verbatim High Fidelity DNA Polymerase; WaferGen's SmartChip PCR services; NuGen Ovation for RNA-Seq; ZyGem's forensicGEM saliva DNA extraction kit

IP Roundup, Nov 10, 2019


University of Illinois, SRU Biosystems, Asahi Kasei, Fred Hutchinson Cancer Research Center, Institute for Systems Biology, Affymetrix, Stanford University, Tecan, CapitalBio

New Product Watch: Nov 3, 2009


Akonni Biosystems, NuGen Technologies

As part of a planned foray into next-generation sequencing technologies, the firm will move into larger housing in San Carlos, and open a new Seattle facility.

By year's end, NuGen plans to launch an RNA-seq sample-preparation kit that allows users to start with less material, and plans to add "many more products for NGS in the near future."


Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.